Beletsi A, Panagi Z, Avgoustakis K
Pharmaceutical Technology Laboratory, Department of Pharmacy, University of Patras, Rion 26500, Patras, Greece.
Int J Pharm. 2005 Jul 14;298(1):233-41. doi: 10.1016/j.ijpharm.2005.03.024.
The basic characteristics and the biodistribution properties of nanoparticles prepared from mixtures of poly(lactide-co-glycolide) (PLGA) with poly(lactide-co-glycolide)-poly(ethylene glycol) (PLGA-PEG) copolymers were investigated. A PLGA(45)-PEG(5) copolymer of relatively low PEG content and a PLGA(5)-PEG(5) copolymer of relatively high PEG content were included in the study. Increasing the PLGA-PEG content of the PLGA/PLGA-PEG mixture, or when PLGA(45)-PEG(5) was replaced by PLGA(5)-PEG(5), a decrease in the size of the nanoparticles and an increase in the rate of PEG loss from the nanoparticles were observed. The blood residence of the PLGA/PLGA(45)-PEG(5) nanoparticles increased as their PLGA-PEG content was increased, reaching maximum blood longevity at 100% PLGA(45)-PEG(5). On the contrary, the blood residence of PLGA/PLGA(5)-PEG(5) nanoparticles exhibited a plateau maximum in the range of 80-100% PLGA(5)-PEG(5). At PLGA-PEG proportions lower than 80%, the PLGA/PLGA(45)-PEG(5) nanoparticles exhibited lower blood residence than the PLGA/PLGA(5)-PEG(5) nanoparticles, whereas at PLGA-PEG proportions higher than 80%, the PLGA/PLGA(45)-PEG(5) nanoparticles exhibited higher blood residence than the PLGA/PLGA(5)-PEG(5) nanoparticles. These findings indicate that apart from the surface PEG content, the biodistribution properties of the PLGA/PLGA-PEG nanoparticles are also influenced by the size of the nanoparticles and the rate of PEG loss from the nanoparticles.
研究了由聚(丙交酯-共-乙交酯)(PLGA)与聚(丙交酯-共-乙交酯)-聚(乙二醇)(PLGA-PEG)共聚物混合物制备的纳米颗粒的基本特性和生物分布特性。研究中包括了PEG含量相对较低的PLGA(45)-PEG(5)共聚物和PEG含量相对较高的PLGA(5)-PEG(5)共聚物。随着PLGA/PLGA-PEG混合物中PLGA-PEG含量的增加,或者当PLGA(45)-PEG(5)被PLGA(5)-PEG(5)取代时,观察到纳米颗粒尺寸减小,纳米颗粒中PEG损失速率增加。PLGA/PLGA(45)-PEG(5)纳米颗粒的血液滞留时间随着其PLGA-PEG含量的增加而增加,在PLGA(45)-PEG(5)含量为100%时达到最长血液寿命。相反,PLGA/PLGA(5)-PEG(5)纳米颗粒的血液滞留时间在PLGA(5)-PEG(5)含量为80%-100%的范围内呈现出平稳的最大值。在PLGA-PEG比例低于80%时,PLGA/PLGA(45)-PEG(5)纳米颗粒的血液滞留时间低于PLGA/PLGA(5)-PEG(5)纳米颗粒,而在PLGA-PEG比例高于80%时,PLGA/PLGA(45)-PEG(5)纳米颗粒的血液滞留时间高于PLGA/PLGA(5)-PEG(5)纳米颗粒。这些发现表明,除了表面PEG含量外,PLGA/PLGA-PEG纳米颗粒的生物分布特性还受到纳米颗粒尺寸和纳米颗粒中PEG损失速率的影响。